Sarepta (SRPT) Q2 Earnings Top Estimates, Sales Lag, View Weak

Sarepta Therapeutics, Inc. (SRPT) posted earnings of 7 cents per share in second-quarter 2024, beating the Zacks Consensus Estimate of breakeven earnings. In the year-ago period, the company posted a loss of 27 cents. The loss included depreciation and amortization expenses and stock-based compensation expenses. Adjusted earnings per share in the quarter stood at 44 cents against the year-ago period's adjusted loss of $1.01 per share. Sarepta recorded total revenues of $362.9 million, up 39% year over year. ...